A Phase I, Single Ascending Dose, Safety and Pharmacokinetic Study of PN0621 in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 24 Jun 2016
At a glance
- Drugs Placulumab (Primary) ; Placulumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Acronyms PN0621/100
- Sponsors Arana Therapeutics
- 04 Dec 2007 Data presented on the 5th December at the IBC Antibody Therapeutics Conference in San Diego.
- 09 Nov 2007 Status changed from initiated to completed.
- 24 May 2007 New trial record.